Fundz

Visgenx Appoints William Pedranti as Chief Executive Officer

PRIVATEJun 05, 2023

Position

Chief Executive Officer

Company

Visgenx, Inc.

William Pedranti
william@visgenx.com
San DiegoBiotechnologyHealth CareTherapeutics

Description

Visgenx, Inc., a biotechnology company focused on developing gene therapies for degenerative retinal diseases, today announced the appointment of William Pedranti, J.D., as Chief Executive Officer. Mr. Pedranti will also join the Company's Board of Directors

Quick answer

Visgenx Appoints William Pedranti as Chief Executive Officer (June 5, 2023). Visgenx, Inc. is based in San Diego, California, United States.

Who is the new Chief Executive Officer at Visgenx, Inc?
Visgenx, Inc. named William Pedranti Chief Executive Officer, announced June 5, 2023.
What did Visgenx, Inc. announce on June 5, 2023?
Visgenx, Inc., a biotechnology company focused on developing gene therapies for degenerative retinal diseases, today announced the appointment of William Pedranti, J.D., as Chief Executive Officer.
What does Visgenx, Inc. do?
Visgenx, Inc. is a biotechnology company focused on developing gene-based therapeutics for degenerative retinal diseases.
Where is Visgenx, Inc. based?
Visgenx, Inc. is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Chemomab Therapeutics Ltd (June 5, 2023), MRM Health (June 7, 2023), BehaVR (June 8, 2023) and LumaBridge (May 31, 2023) also announced leadership changes within 45 days of Visgenx, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Visgenx, Inc., and when

A new leader at Visgenx, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Visgenx, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Visgenx, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Visgenx, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Visgenx, Inc.

Location

3210 Merryfield Row

San Diego, California, United States

About

Visgenx, Inc. is a biotechnology company focused on developing gene-based therapeutics for degenerative retinal diseases. Visgenx' initial product is VGX-0111, a gene therapy candidate being developed for the treatment of dry Age-related Macular Degeneration (AMD). Close to 200 million people suffer from dry AMD globally; it is a leading cause of blindness. VGX-0111 is based on the ELOVL2 gene, which is required for the biosynthesis of lipids necessary for the function and survival of retinal cells. ELVOL2 expression declines with aging which may be an underlying pathology of dry AMD. VGX-0111 is intended to restore a normal level of ELOVL2 expression thereby slowing or halting the vision loss resulting from dry AMD. For more information on Visgenx, visit www.visgenx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Visgenx, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Marty
Likely contact at this company
••••••••@••••••••

See Marty's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Visgenx, Inc.'s next move

Learn about Strategic plan

Visgenx, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.